|
1.
|
Bak S, Gaist D, Sindrup SH, Skytthe A and
Christensen K: Genetic liability in stroke: a long-term follow-up
study of Danish twins. Stroke. 33:769–774. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Tournier-Lasserve E: New players in the
genetics of stroke. N Engl J Med. 347:1711–1712. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Touzé E and Rothwell PM: Heritability of
ischaemic stroke in women compared with men: a genetic
epidemiological study. Lancet Neurol. 6:125–133. 2007.PubMed/NCBI
|
|
4.
|
Matarín M, Brown WM, Scholz S, et al: A
genome-wide genotyping study in patients with ischaemic stroke:
initial analysis and data release. Lancet Neurol. 6:414–420.
2007.PubMed/NCBI
|
|
5.
|
Kubo M, Hata J, Ninomiya T, et al: A
nonsynonymous SNP in PRKCH (protein kinase C eta) increases the
risk of cerebral infarction. Nat Genet. 39:212–217. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Ikram MA, Seshadri S, Bis JC, et al:
Genomewide association studies of stroke. N Engl J Med.
360:1718–1728. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Irie F, Iso H, Sairenchi T, et al: The
relationships of proteinuria, serum creatinine, glomerular
filtration rate with cardiovascular disease mortality in Japanese
general population. Kidney Int. 69:1264–1271. 2006. View Article : Google Scholar
|
|
8.
|
Yahalom G, Schwartz R, Schwammenthal Y, et
al: Chronic kidney disease and clinical outcome in patients with
acute stroke. Stroke. 40:1296–1303. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Muntner P, He J, Hamm L, Loria C and
Whelton PK: Renal insufficiency and subsequent death resulting from
cardiovascular disease in the United States. J Am Soc Nephrol.
13:745–753. 2002.PubMed/NCBI
|
|
10.
|
Matsuo S, Imai E, Horio M, et al: Revised
equations for estimated GFR from serum creatinine in Japan. Am J
Kidney Dis. 53:982–992. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Levey AS, Eckardt KU, Tsukamoto Y, et al:
Definition and classification of chronic kidney disease: a position
statement from Kidney Disease: Improving Global Outcomes (KDIGO).
Kidney Int. 67:2089–2100. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
A committee established by the Director of
the National Institute of Neurological Disorders and Stroke,
National Institutes of Health: Special Report from the National
Institute of Neurological Disorders and Stroke. Classification of
Cerebrovascular Diseases III. Stroke. 21:637–676. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Yamada Y, Fuku N, Tanaka M, et al:
Identification of CELSR1 as a susceptibility gene for
ischemic stroke in Japanese individuals by a genome-wide
association study. Atherosclerosis. 207:144–149. 2009.
|
|
14.
|
Oguri M, Kato K, Yokoi K, et al:
Association of a polymorphism of BCHE with ischemic stroke
in Japanese individuals with chronic kidney disease. Mol Med Rep.
2:779–785. 2009.PubMed/NCBI
|
|
15.
|
Yamada Y, Kato K, Oguri M, et al:
Association of genetic variants with atherothrombotic cerebral
infarction among Japanese individuals with metabolic syndrome. Int
J Mol Med. 21:801–808. 2008.PubMed/NCBI
|
|
16.
|
Yamada Y, Metoki N, Yoshida H, et al:
Genetic factors for ischemic and hemorrhagic stroke in Japanese
individuals. Stroke. 39:2211–2218. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Yamada Y, Metoki N, Yoshida H, et al:
Genetic risk for ischemic and hemorrhagic stroke. Arterioscler
Thromb Vasc Biol. 26:1920–1925. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Itoh Y, Mizuki N, Shimada T, et al:
High-throughput DNA typing of HLA-A, -B, -C and -DRB1 loci by a
PCR-SSOP-Luminex method in the Japanese population. Immunogenetics.
57:717–729. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Benjamini Y and Hochberg Y: Controlling
the false discovery rate: a practical and powerful approach to
multiple testing. J Royal Stat Soc Ser B. 57:289–300. 1995.
|
|
20.
|
Goldstein LB, Adams R, Becker K, et al:
Primary prevention of ischemic stroke: a statement for healthcare
professionals from the Stroke Council of the American Heart
Association. Stroke. 32:280–299. 2001. View Article : Google Scholar
|
|
21.
|
Humphries SE and Morgan L: Genetic risk
factors for stroke and carotid atherosclerosis: insights into
pathophysiology from candidate gene approaches. Lancet Neurol.
3:227–235. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Masiakowski P and Carroll RD: A novel
family of cell surface receptors with tyrosine kinase-like domain.
J Biol Chem. 267:26181–26190. 1992.PubMed/NCBI
|
|
23.
|
Forrester WC: The Ror receptor tyrosine
kinase family. Cell Mol Life Sci. 59:83–96. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Stommel JM, Kimmelman AC, Ying H, et al:
Coactivation of receptor tyrosine kinases affects the response of
tumor cells to targeted therapies. Science. 318:287–290. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Schlessinger J: Cell signaling by receptor
tyrosine kinases. Cell. 103:211–225. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Yoda A, Oishi I and Minami Y: Expression
and function of the Ror-family receptor tyrosine kinases during
development: lessons from genetic analyses of nematodes, mice and
humans. J Recept Signal Transduct Res. 23:1–15. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Afzal AR, Rajab A, Fenske CD, et al:
Recessive Robinow syndrome, allelic to dominant brachydactyly type
B, is caused by mutation of ROR2. Nat Genet. 25:419–422. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Oldridge M, Fortuna AM, Maringa M, et al:
Dominant mutations in ROR2, encoding an orphan receptor tyrosine
kinase, cause brachydactyly type B. Nat Genet. 24:275–278. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Katoh M and Katoh M: Comparative genomics
on ROR1 and ROR2 orthologs. Oncol Rep. 14:1381–1384.
2005.PubMed/NCBI
|
|
30.
|
Wright TM, Brannon AR, Gordan JD, et al:
Ror2, a developmentally regulated kinase, promotes tumor growth
potential in renal cell carcinoma. Oncogene. 28:2513–2523. 2009.
View Article : Google Scholar : PubMed/NCBI
|
